Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL664894 | 0.83 | P2RX7 (0.36) | ALDH1A1 | |
| SCHEMBL4315681 | 0.79 | PNMT (0.33) | — | |
| SCHEMBL663479 | 0.78 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL19376882 | 0.74 | NPC1 (0.36) | ALDH1A1 | |
| SCHEMBL662636 | 0.69 | AKR1B1 (0.31) | AKR1B1 | |
| SCHEMBL16040906 | 0.69 | ADRB2 (0.44) | ALDH1A1 | |
| SCHEMBL1518362 | 0.68 | AKR1C4 (0.32) | ALDH1A1 | |
| SCHEMBL662617 | 0.67 | XDH (0.35) | AKR1B1ALDH1A1 | |
| SCHEMBL663581 | 0.66 | SLC6A4 (0.44) | — | |
| SCHEMBL1071399 | 0.65 | NMT1 (0.34) | GPR35AKR1B1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120046293-A1 | RENIN INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2012-02-23 | — | — | US | disclosed |
| US-8063105-B2 | Renin inhibitors | MERCK CANADA INC. (CA) | 2011-11-22 | — | — | US | disclosed |
| US-20090281103-A1 | Renin Inhibitors | MERCK CANADA INC. (CA) | 2009-11-12 | — | — | US | disclosed |
| EP-1910272-A1 | RENIN INHIBITORS | Merck Frosst Canada Ltd. (CA) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007009250-A1 | RENIN INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2007-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046293-A1 | RENIN INHIBITORS | REN, ACE, AGTR1 | GPR35 1848/4885AKR1B1 333/4885ALDH1A1 2104/4885 |
| US-20090281103-A1 | Renin Inhibitors | REN, ACE, AGT | GPR35 1273/4885AKR1B1 170/4885ALDH1A1 2078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.